Moleculin Biotech, Inc. Capital Expenditures Incurred but Not yet Paid
Moleculin Biotech, Inc. (MBRX) reported Capital Expenditures Incurred but Not yet Paid of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-21.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2025-03-21
- Moleculin Biotech, Inc. capital expenditures incurred but not yet paid for the quarter ending 2021-12-31 was $5.00K.
- Moleculin Biotech, Inc. capital expenditures incurred but not yet paid for the quarter ending 2021-09-30 was $0.00, a 100.00% decline year-over-year.
- Moleculin Biotech, Inc. capital expenditures incurred but not yet paid for the quarter ending 2021-06-30 was $0.00.
- Moleculin Biotech, Inc. capital expenditures incurred but not yet paid for the quarter ending 2021-03-31 was $0.00, a 100.00% decline year-over-year.
- Moleculin Biotech, Inc. capital expenditures incurred but not yet paid for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- Moleculin Biotech, Inc. capital expenditures incurred but not yet paid for fiscal 2023 was $26.00K.
- Moleculin Biotech, Inc. capital expenditures incurred but not yet paid for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- Moleculin Biotech, Inc. capital expenditures incurred but not yet paid for fiscal 2021 was $5.00K.
| Period end | Capital Expenditures Incurred but Not yet Paid 3 month | Capital Expenditures Incurred but Not yet Paid 6 month | Capital Expenditures Incurred but Not yet Paid 9 month | Capital Expenditures Incurred but Not yet Paid 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-03-21 | |||
| 2023-12-31 | $26.00K 10-K · filed 2025-03-21 | |||
| 2022-12-31 | $0.00 10-K · filed 2024-03-22 | |||
| 2022-06-30 | $3.00K 10-Q · filed 2022-08-12 | |||
| 2021-12-31 | $5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | $5.00K derived: sum of 2 quarters · filed 2022-03-24 | $5.00K derived: sum of 3 quarters · filed 2022-08-12 | $5.00K 10-K · filed 2022-03-24 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $0.00 derived: sum of 2 quarters · filed 2022-08-12 | $0.00 10-Q · filed 2021-11-10 | -$316.00K derived: sum of 4 quarters · filed 2022-08-12 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $0.00 10-Q · filed 2022-08-12 | -$316.00K derived: sum of 3 quarters · filed 2022-08-12 | -$21.00K derived: sum of 4 quarters · filed 2022-08-12 |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-12 | -$316.00K derived: sum of 2 quarters · filed 2022-03-24 | -$21.00K derived: sum of 3 quarters · filed 2022-03-24 | -$23.00K derived: sum of 4 quarters · filed 2022-03-24 |
| 2020-12-31 | -$316.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | -$21.00K derived: sum of 2 quarters · filed 2022-03-24 | -$23.00K derived: sum of 3 quarters · filed 2022-03-24 | $0.00 10-K · filed 2022-03-24 |
| 2020-09-30 | $295.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $293.00K derived: sum of 2 quarters · filed 2021-11-10 | $316.00K 10-Q · filed 2021-11-10 | $317.00K derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | -$2.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | $21.00K 10-Q · filed 2021-08-11 | $22.00K derived: sum of 3 quarters · filed 2021-08-11 | $22.00K derived: sum of 4 quarters · filed 2021-08-11 |
| 2020-03-31 | $23.00K 10-Q · filed 2021-05-12 | $24.00K derived: sum of 2 quarters · filed 2021-05-12 | $24.00K derived: sum of 3 quarters · filed 2021-05-12 | $4.00K derived: sum of 4 quarters · filed 2021-05-12 |
| 2019-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-24 | $1.00K derived: sum of 2 quarters · filed 2021-03-24 | -$19.00K derived: sum of 3 quarters · filed 2021-03-24 | $22.00K 10-K · filed 2021-03-24 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | -$20.00K derived: sum of 2 quarters · filed 2020-11-12 | $21.00K 10-Q · filed 2020-11-12 | -$92.00K derived: sum of 4 quarters · filed 2020-11-12 |
| 2019-06-30 | -$20.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | $21.00K 10-Q · filed 2020-08-12 | -$92.00K derived: sum of 3 quarters · filed 2020-08-12 | $44.00K derived: sum of 4 quarters · filed 2020-08-12 |
| 2019-03-31 | $41.00K 10-Q · filed 2020-05-11 | -$72.00K derived: sum of 2 quarters · filed 2020-05-11 | $64.00K derived: sum of 3 quarters · filed 2020-05-11 | $64.00K derived: sum of 4 quarters · filed 2020-05-11 |
| 2018-12-31 | -$113.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-19 | $23.00K derived: sum of 2 quarters · filed 2020-03-19 | $23.00K derived: sum of 3 quarters · filed 2020-03-19 | $23.00K 10-K · filed 2020-03-19 |
| 2018-09-30 | $136.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $136.00K derived: sum of 2 quarters · filed 2019-11-12 | $136.00K 10-Q · filed 2019-11-12 | $136.00K derived: sum of 4 quarters · filed 2019-11-12 |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-16 | $0.00 10-Q · filed 2019-08-16 | $0.00 derived: sum of 3 quarters · filed 2019-08-16 | |
| 2018-03-31 | $0.00 10-Q · filed 2019-05-13 | $0.00 derived: sum of 2 quarters · filed 2019-05-13 | ||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-21 | $0.00 10-K · filed 2019-02-21 | ||
| 2017-09-30 | $0.00 10-Q · filed 2018-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |